Related references
Note: Only part of the references are listed.Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia
Yu-Chung Chuang et al.
CLINICAL INFECTIOUS DISEASES (2017)
Evidence To Support Continuation of Statin Therapy in Patients with Staphylococcus aureus Bacteremia
Aisling R. Caffrey et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
Kimberly C. Claeys et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Safety of treatment with high-dose daptomycin in 102 patients with infective endocarditis
Emanuele Durante-Mangoni et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Impact of the Combination of Daptomycin and Trimethoprim-Sulfamethoxazole on Clinical Outcomes in Methicillin-Resistant Staphylococcus aureus Infections
Kimberly C. Claeys et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association
Larry M. Baddour et al.
CIRCULATION (2015)
2015 ESC Guidelines for the management of infective endocarditis
Gilbert Habib et al.
EUROPEAN HEART JOURNAL (2015)
Determination of Risk Factors for Recurrent Methicillin-Resistant Staphylococcus aureus Bacteremia in a Veterans Affairs Healthcare System Population
Justin Albertson et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2015)
Nasal screening is useful in excluding methicillin-resistant Staphylococcus aureus in ventilator-associated pneumonia
Jens Langsjoen et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2014)
Association Between Vancomycin Minimum Inhibitory Concentration and Mortality Among Patients With Staphylococcus aureus Bloodstream Infections A Systematic Review and Meta-analysis
Andre C. Kalil et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
High-Dose Daptomycin Therapy for Left-Sided Infective Endocarditis: a Prospective Study from the International Collaboration on Endocarditis
Manuela Carugati et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients
Chung-Chih Lai et al.
BMC INFECTIOUS DISEASES (2013)
Considerations for Higher Doses of Daptomycin in Critically Ill Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia
Marco Falcone et al.
CLINICAL INFECTIOUS DISEASES (2013)
Early Use of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia With Vancomycin Minimum Inhibitory Concentration >1 mg/L: A Matched Cohort Study
Kyle P. Murray et al.
CLINICAL INFECTIOUS DISEASES (2013)
A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis
Ravina Kullar et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Evaluation of Daptomycin Non-Susceptible Staphylococcus aureus for Stability, Population Profiles, mprF Mutations, and Daptomycin Activity
Molly E. Steed et al.
INFECTIOUS DISEASES AND THERAPY (2013)
β-Lactams Increase the Antibacterial Activity of Daptomycin against Clinical Methicillin-Resistant Staphylococcus aureus Strains and Prevent Selection of Daptomycin-Resistant Derivatives
Shrenik Mehta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Role of disease risk scores in comparative effectiveness research with emerging therapies
Robert J. Glynn et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
Impact of Dose De-Escalation and Escalation on Daptomycin's Pharmacodynamics against Clinical Methicillin-Resistant Staphylococcus aureus Isolates in an In Vitro Model
Celine Vidaillac et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Evaluation of Ceftaroline Activity versus Daptomycin (DAP) against DAP-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Strains in an In Vitro Pharmacokinetic/Pharmacodynamic Model
Molly Steed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010)
Helio S. Sader et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
Peter C. Austin
MULTIVARIATE BEHAVIORAL RESEARCH (2011)
Daptomycin Exposure and the Probability of Elevations in the Creatine Phosphokinase Level: Data from a Randomized Trial of Patients with Bacteremia and Endocarditis
Sujata M. Bhavnani et al.
CLINICAL INFECTIOUS DISEASES (2010)
High-dose daptomycin in documented Staphylococcus aureus infections
Matteo Bassetti et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Safety and Clinical Outcomes when Utilizing High-Dose (≥8 mg/kg) Daptomycin Therapy
Pamela A. Moise et al.
ANNALS OF PHARMACOTHERAPY (2009)
Relationship between Susceptibility to Daptomycin In Vitro and Activity In Vivo in a Rabbit Model of Aortic Valve Endocarditis
H. F. Chambers et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Safety of High-Dose Intravenous Daptomycin Treatment: Three-Year Cumulative Experience in a Clinical Program
D. A. Figueroa et al.
CLINICAL INFECTIOUS DISEASES (2009)
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
Leonard A. Mermel et al.
CLINICAL INFECTIOUS DISEASES (2009)
Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetations
Warren E. Rose et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations
Warren E. Rose et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis:: an in vitro and in vivo simulation using historical and current dosing strategies
Warren E. Rose et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Influence of morbid obesity on the single-dose pharmacokinetics of daptomycin
Manjunath P. Pai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Short-course gentamicin in combination with Daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations
BT Tsuji et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Classification and regression tree analysis in public health: Methodological review and comparison with logistic regression
SC Lemon et al.
ANNALS OF BEHAVIORAL MEDICINE (2003)
Share Paper
